Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice
- PMID: 11254584
- PMCID: PMC98156
- DOI: 10.1128/IAI.69.4.2277-2285.2001
Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice
Abstract
Resident bacteria are incriminated in the pathogenesis of experimental colitis and inflammatory bowel diseases. We investigated the relative roles of various enteric bacteria populations in the induction and perpetuation of experimental colitis. HLA-B27 transgenic rats received antibiotics (ciprofloxacin, metronidazole, or vancomycin-imipenem) in drinking water or water alone in either prevention or treatment protocols. Mice were treated similarly with metronidazole or vancomycin-imipenem before or after receiving 5% dextran sodium sulfate (DSS). Germfree transgenic rats were colonized with specific-pathogen-free enteric bacteria grown overnight either in anaerobic or aerobic atmospheres. Nontransgenic rats colonized with anaerobic bacteria served as negative controls. Although preventive metronidazole significantly attenuated colitis in transgenic rats and DSS-treated mice, it had no therapeutic benefit once colitis was established. Ciprofloxacin also partially prevented but did not treat colitis in B27 transgenic rats. In both animal models vancomycin-imipenem most effectively prevented and treated colitis. Germfree transgenic rats reconstituted with enteric bacteria grown under anaerobic conditions had more aggressive colitis than those associated with aerobic bacteria. These results suggest that a subset of resident luminal bacteria induces colitis, but that a complex interaction of commensal aerobic and anaerobic bacteria provides the constant antigenic drive for chronic immune-mediated colonic inflammation.
Figures

) the onset of colitis. All rats
were killed at 4 months of age. n = 8 or 9 rats in each
group. ∗, P < 0.05 versus TG water controls. Cipro,
ciprofloxacin; Metro, metronidazole; Vanco, vancomycin. Error bars
indicate SEMs.
)
the onset of colitis. ∗, P < 0.05 versus TG water.
Cipro, ciprofloxacin; Metro, metronidazole; Vanco, vancomycin. Error
bars indicate SEMs.
, treatment;
■, water control. Error bars indicate SEMs.
References
-
- Aranda R, Sydora B C, McAllister P L, Binder S W, Yang H Y, Targan S R, Kronenberg M. Analysis of intestinal lymphocytes in mouse colitis mediated by transfer of CD4+, CD45RBhigh T cells to SCID recipients. J Immunol. 1997;158:3464–3473. - PubMed
-
- Arndt H, Palitzsch K D, Grisham M B, Granger D N. Metronidazole inhibits leukocyte-endothelial cell adhesion in rat mesenteric venules. Gastroenterology. 1994;106:1271–1276. - PubMed
-
- Arnold G L, Patel H, Beaves M, Boyd H. Ciprofloxacin in active Crohn's disease: preliminary report of a six month randomized placebo controlled study. Gastroenterology. 1999;116:A664.
-
- Axelsson L G, Landstrom E, Bylund-Fellenius A C. Experimental colitis induced by dextran sulphate sodium in mice: beneficial effects of sulphasalazine and olsalazine. Aliment Pharmacol Ther. 1998;12:925–934. - PubMed
-
- Axelsson L G, Landstrom E, Goldschmidt T J, Gronberg A, Bylund-Fellenius A C. Dextran sulfate sodium (DSS) induced experimental colitis in immunodeficient mice: effects in CD4(+) -cell depleted, athymic and NK- cell depleted SCID mice. Inflamm Res. 1996;45:181–191. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
